Gareth Mcdonald from in-pharmatechnologist.com shared his views on the impact of FDA committing a forecasted $5 million of its newly approved budget to visit Chinese drug plants. The reason for the increase attention in China is that FDA wants to focus on facilities...
Cassandra Leger from bioresearchonline.com covered recent development regarding the National Institute of Health’s (NIH) plans to create a program to expedite research designed to treat brain disorders. The NIH is planning on turning their new biospecimens...
Plan on joining us at the Indiana Medical Device Manufacturers Council (IMDMC) event entitled “Regulatory 101” on May 15, 2014. Gretchen Bowker, COO of Pearl Pathways will be speaking at the event at the Montage Banquet Hall in Indianapolis, Indiana. This is a full...
Emily Mullin from fiercebiotechresearch.com wrote an article about an alarming finding among global research trends. Mullin introduced the article by sharing findings from an analysis of over 4 million scientific articles by James Evans and co-author Jae-Mahn Shim...
Ed Silverman from the Wall Street Journal wrote an interesting article on the need for more social media presence from pharmaceutical companies in clinical trial arena. Silverman feels that pharma companies may be dropping the ball on using social media to promote and...
